Tuberculosis is one of the most common infectious diseases and infectious causes of death
worldwide. Over the last decades, significant research effort has been directed towards …

The gut microbiota has emerged as a key human health and disease determinant. However,
there is a significant knowledge gap regarding the composition, diversity, and function of the …

Microplastics (MP) and nanoplastics (NP) have been found in multiple environments and
creatures. However, their effects on the airway microbiota still remain poorly understood. In …

Emerging evidence indicates that the gut microbiome contributes to the host immune
response to infectious diseases. Here, to explore the role of the gut microbiome in the host …

Introduction Growing evidence indicates that variations in the composition of the gut
microbiota are linked to the onset and progression of chronic respiratory diseases (CRDs) …

Tuberculosis (TB) has remained at the forefront of the global infectious disease burden for
centuries. Concerted global efforts to eliminate TB have been hindered by the complexity of …

Introduction Recent studies have provided insights into the important contribution of gut
microbiota in the development of Pulmonary Tuberculosis (PTB). As a chronic consumptive …

The tuberculosis (TB) burden remains a significant global public health concern, especially
in less developed countries. While pulmonary tuberculosis (PTB) is the most common form …

Introduction This systematic review evaluates the gut microbiota (GM) status in tuberculosis
(TB) patients compared to healthy volunteers due to the disease or its treatment. Areas …

Summary Background Xpert MTB/RIF Ultra (Ultra) is a widely used rapid front-line
tuberculosis and rifampicin-susceptibility testing. Mycobacterium Growth Indicator Tube …